KHALIFA KUSH EXPANDS GLOBAL FOOTPRINT WITH ENTRY INTO AUSTRALIA'S MEDICAL CANNABIS MARKET

Khalifa Kush Expands Global Footprint With Australian Debut

Khalifa Kush, the cannabis brand founded by multi-platinum selling, GRAMMY and Golden Globe nominated recording artist Wiz Khalifa, announces its continued international expansion with entry into the Australian medical cannabis market. Marking its sixth global market, Khalifa Kush will partner with leading cannabis company Endoca to bring its signature products to patients across Australia.

Through this strategic partnership, Khalifa Kush will introduce an initial portfolio of premium flower and edible products to the new market. The agreement provides distribution to pharmacies and clinics nationally, across all states and territories of Australia.

“Australia’s well-regulated market and patient-focused approach align perfectly with our brand values – we’re not entering every market, we’re entering the right markets,” said DJ Saul, CEO of Khalifa Kush. “Endoca is the perfect partner to help us maintain brand integrity and deliver the quality that patients and consumers expect from KK.”

Australia represents a key milestone in Khalifa Kush’s global growth strategy. With a rapidly expanding medical cannabis market, a stable and mature regulatory framework and strong local demand driven in part by Wiz Khalifa’s established fanbase, the region offers an ideal environment for the brand’s continued international presence. As one of the fastest-growing markets globally, it presents a clear opportunity for trusted, consumer-friendly brands like Khalifa Kush. The brand is well positioned to meet increasing patient demand through high-quality, consistent products backed by its proprietary genetics.

“This partnership brings an internationally recognized cannabis genetics company into Australia’s regulated medical framework,” said Johnny Jusic, Managing Director at Endoca. “We’re excited to work with Khalifa Kush because of the original genetics and cultivar heritage behind the brand, and our focus is on introducing that heritage to the Australian market the right way — through compliant, healthcare-led channels that meet local regulatory and manufacturing standards.